A&I Financial Services LLC Takes Position in Phibro Animal Health Corporation $PAHC

Key Points

• A&I Financial Services LLC acquired 29,360 shares of Phibro Animal Health Corporation, valued at approximately $750,000, making it the 29th largest holding in their portfolio.
• The company announced a quarterly dividend of $0.12 per share, with an annualized dividend yield of 1.2% and a payout ratio of 40.68%.
• Phibro reported earnings of $0.57 per share for the last quarter, exceeding the consensus estimate of $0.52, and set its FY 2026 guidance at 2.520-2.700 EPS.

A&I Financial Services LLC acquired a new position in Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 29,360 shares of the company's stock, valued at approximately $750,000. Phibro Animal Health accounts for about 0.4% of A&I Financial Services LLC's portfolio, making the stock its 29th largest position. A&I Financial Services LLC owned 0.07% of Phibro Animal Health as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently added to or reduced their stakes in the company. National Bank of Canada FI bought a new position in Phibro Animal Health during the first quarter worth about $30,000. Lazard Asset Management LLC boosted its holdings in Phibro Animal Health by 2,739.7% in the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after buying an additional 1,589 shares during the period. Curat Global LLC bought a new position in Phibro Animal Health in the 1st quarter worth approximately $146,000. Quantbot Technologies LP grew its stake in Phibro Animal Health by 53.8% in the 1st quarter. Quantbot Technologies LP now owns 7,870 shares of the company's stock valued at $168,000 after buying an additional 2,754 shares in the last quarter. Finally, Cetera Investment Advisers bought a new stake in Phibro Animal Health during the 4th quarter valued at $204,000. Hedge funds and other institutional investors own 99.34% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on PAHC. Zacks Research downgraded Phibro Animal Health from a "strong-buy" rating to a "hold" rating in a research note on Thursday, August 28th. Morgan Stanley set a $34.00 price objective on shares of Phibro Animal Health in a research report on Thursday, August 28th. BNP Paribas Exane upgraded shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 target price on the stock in a research note on Monday, June 16th. Bank of America upped their price target on shares of Phibro Animal Health from $19.00 to $27.00 and gave the stock an "underperform" rating in a report on Friday, August 29th. Finally, BNP Paribas raised Phibro Animal Health to a "hold" rating in a research note on Monday, June 16th. One analyst has rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Reduce" and an average target price of $28.40.

Insider Transactions at Phibro Animal Health

In other Phibro Animal Health news, CEO Jack Bendheim sold 14,080 shares of Phibro Animal Health stock in a transaction that occurred on Tuesday, September 9th. The stock was sold at an average price of $40.33, for a total value of $567,846.40. Following the transaction, the chief executive officer directly owned 45,400 shares of the company's stock, valued at $1,830,982. The trade was a 23.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 50.07% of the stock is currently owned by insiders.

Phibro Animal Health Price Performance

NASDAQ PAHC traded down $0.68 during trading hours on Friday, reaching $39.86. 554,817 shares of the stock traded hands, compared to its average volume of 410,444. The company has a debt-to-equity ratio of 2.46, a current ratio of 2.76 and a quick ratio of 1.25. The stock has a 50 day simple moving average of $32.87 and a two-hundred day simple moving average of $26.11. Phibro Animal Health Corporation has a 1 year low of $16.16 and a 1 year high of $41.57. The company has a market cap of $1.62 billion, a price-to-earnings ratio of 33.78, a price-to-earnings-growth ratio of 1.18 and a beta of 0.88.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings data on Wednesday, August 27th. The company reported $0.57 EPS for the quarter, beating the consensus estimate of $0.52 by $0.05. The firm had revenue of $378.70 million for the quarter, compared to analyst estimates of $362.24 million. Phibro Animal Health had a return on equity of 32.14% and a net margin of 3.73%. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. On average, analysts predict that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd will be issued a $0.12 dividend. The ex-dividend date is Wednesday, September 3rd. This represents a $0.48 annualized dividend and a dividend yield of 1.2%. Phibro Animal Health's payout ratio is currently 40.68%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.